Bilaketaren emaitzak - Jeffrey Perl

Findu emaitzak
  1. 1
    Increasing Peritoneal Dialysis Use in Response to the COVID-19 Pandemic: Will It Go Viral?

    Increasing Peritoneal Dialysis Use in Response to the COVID-19 Pandemic: Will It Go Viral? nork Edwina A. Brown, Jeffrey Perl

    Argitaratua 2020
    Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Center-Centered in a Patient-Centered World?

    Center-Centered in a Patient-Centered World? nork Thyago Proença de Moraes, Jeffrey Perl

    Argitaratua 2016
    Testu osoa
    Carta
    Gogokoenen artean sartu
    Gorde:
  3. 3
    Sleep disorders in end-stage renal disease: ‘Markers of inadequate dialysis?’

    Sleep disorders in end-stage renal disease: ‘Markers of inadequate dialysis?’ nork Jeffrey Perl, Mark L. Unruh, Christopher T. Chan

    Argitaratua 2006
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    Practical Considerations When Prescribing Icodextrin: A Narrative Review

    Practical Considerations When Prescribing Icodextrin: A Narrative Review nork Samuel A. Silver, Ziv Harel, Jeffrey Perl

    Argitaratua 2014
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both?

    The biocompatibility of neutral pH, low-GDP peritoneal dialysis solutions: benefit at bench, bedside, or both? nork Jeffrey Perl, Sharon J. Nessim, Joanne M. Bargman

    Argitaratua 2011
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Peritoneal Protein Clearance and not Peritoneal Membrane Transport Status Predicts Survival in a Contemporary Cohort of Peritoneal Dialysis Patients

    Peritoneal Protein Clearance and not Peritoneal Membrane Transport Status Predicts Survival in a Contemporary Cohort of Peritoneal Dialysis Patients nork Jeffrey Perl, Kit Huckvale, Michelle Chellar, Biju John, Simon Davies

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  7. 7
    Peritoneal Dialysis in Critically Ill Patients

    Peritoneal Dialysis in Critically Ill Patients nork Muthana Al Sahlawi, Daniela Ponce, David M. Charytan, Brett Cullis, Jeffrey Perl

    Argitaratua 2022
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  8. 8
    The Frequency and Outcomes of Kidney Replacement Therapy Transitions in Canada

    The Frequency and Outcomes of Kidney Replacement Therapy Transitions in Canada nork Louis‐Charles Desbiens, Karthik Tennankore, Jeffrey Perl, Christopher T. Chan, Annie‐Claire Nadeau‐Fredette

    Argitaratua 2025
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    The risk of peritonitis after an exit site infection: a time-matched, case–control study

    The risk of peritonitis after an exit site infection: a time-matched, case–control study nork Alissa Lloyd, Navdeep Tangri, Leigh Anne Shafer, Claudio Rigatto, Jeffrey Perl, Paul Komenda, Manish M. Sood

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Impact of Dialysis Modality on Survival after Kidney Transplant Failure

    Impact of Dialysis Modality on Survival after Kidney Transplant Failure nork Jeffrey Perl, Omar Hasan, Joanne M. Bargman, Depeng Jiang, Yingbo Na, John S. Gill, Sarbjit V. Jassal

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis

    The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis nork Ziv Harel, Cameron Gilbert, Ron Wald, Chaim M. Bell, Jeffrey Perl, David N. Juurlink, Joseph Beyene, Prakesh S. Shah

    Argitaratua 2012
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD

    Comparisons between Novel Oral Anticoagulants and Vitamin K Antagonists in Patients with CKD nork Ziv Harel, Michelle Sholzberg, Prakesh S. Shah, Katerina Pavenski, Shai Har-El, Ron Wald, Chaim M. Bell, Jeffrey Perl

    Argitaratua 2014
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Socioeconomic Factors and Racial and Ethnic Differences in the Initiation of Home Dialysis

    Socioeconomic Factors and Racial and Ethnic Differences in the Initiation of Home Dialysis nork Jenny I. Shen, Lucia Chen, Sitaram Vangala, Lynn Leng, Anuja Shah, Anjali Saxena, Jeffrey Perl, Keith C. Norris

    Argitaratua 2020
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Changes in Patient and Technique Survival over Time among Incident Peritoneal Dialysis Patients in Canada

    Changes in Patient and Technique Survival over Time among Incident Peritoneal Dialysis Patients in Canada nork Jeffrey Perl, Ron Wald, Joanne M. Bargman, Yingbo Na, Sarbjit V. Jassal, Arsh K. Jain, Louise Moist, Sharon J. Nessim

    Argitaratua 2012
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study

    Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study nork Jeffrey Perl, J. Zhang, Brenda W. Gillespie, Björn Wíkström, Joan Fort, Takeshi Hasegawa, Douglas S. Fuller, R. Pisoni, Bruce Robinson, Francesca Tentori

    Argitaratua 2012
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Hemodialysis Vascular Access Modifies the Association between Dialysis Modality and Survival

    Hemodialysis Vascular Access Modifies the Association between Dialysis Modality and Survival nork Jeffrey Perl, Ron Wald, Philip A. McFarlane, Joanne M. Bargman, Edward F. Vonesh, Yingbo Na, Sarbjit V. Jassal, Louise Moist

    Argitaratua 2011
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    A Palliative Approach to Dialysis Care

    A Palliative Approach to Dialysis Care nork Vanessa Grubbs, Alvin H. Moss, Lewis M. Cohen, Michael J. Fischer, Michael J. Germain, Sarbjit V. Jassal, Jeffrey Perl, Daniel E. Weiner, Rajnish Mehrotra

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    The Risk of Major Hemorrhage with CKD

    The Risk of Major Hemorrhage with CKD nork Amber O. Molnar, Sarah E. Bota, Amit X. Garg, Ziv Harel, Ngan N. Lam, Eric McArthur, Gihad Nesrallah, Jeffrey Perl, Manish M. Sood

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Hospitalizations in Dialysis Patients in Canada: A National Cohort Study

    Hospitalizations in Dialysis Patients in Canada: A National Cohort Study nork Amber O. Molnar, Louise Moist, Scott Klarenbach, Jean‐Philippe Lafrance, Soojin Kim, Karthik Tennankore, Jeffrey Perl, Joanne Kappel, Michael Terner, Jagbir Gill, Manish M. Sood

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    #5529 RED BLOOD CELL TRANSFUSION RATES IN THE INTERNATIONAL DOPPS PROGRAM (2012–2022): HEMODIALYSIS, PERITONEAL DIALYSIS, AND NON-DIALYSIS CKD POPULATIONS

    #5529 RED BLOOD CELL TRANSFUSION RATES IN THE INTERNATIONAL DOPPS PROGRAM (2012–2022): HEMODIALYSIS, PERITONEAL DIALYSIS, AND NON-DIALYSIS CKD POPULATIONS nork Angelo Karaboyas, Charlotte Tu, Jake Hunnicutt, Anna Richards, Timothy Pham, Elham Asgari, Fitsum Guebre‐Egziabher, Elke Schäeffner, António Alberto Lopes, Jeffrey Perl, Roberto Pecoits–Filho

    Argitaratua 2023
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: